Mutations in the v-Rel transactivation domain indicate altered phosphorylation and identify a subset of NF-κB-regulated cell death inhibitors important for v-Rel transforming activity

Molecular and Cellular Biology

Volumn 23, Issue 5, 2003, Pages 1520-1533

  Rayet, Béatrice ^a,c   Fan, Yongjun ^a   Gélinas, Céline ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN; PHOSPHOAMINO ACID; PROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; SERINE; TRANSCRIPTION FACTOR REL; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; AMINO ACID SUBSTITUTION; ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL DEATH; CELL SURVIVAL; CELL TRANSFORMATION; CHICKEN; CONTROLLED STUDY; DNA BINDING; DNA PROTEIN COMPLEX; DNA SEQUENCE; GENE; GENE BCL 2; GENE BCL XL; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; LEUKEMIA; LYMPHOID CELL; LYMPHOMA; MALIGNANT TRANSFORMATION; MOLECULAR MECHANICS; MOLECULAR RECOGNITION; NONHUMAN; PEPTIDE ANALYSIS; PEPTIDE MAPPING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SYNTHESIS; SEQUENCE ANALYSIS; SPLEEN CELL; TRANSACTIVATION;

ANIMALS; ASPARTIC ACID; BCL-X PROTEIN; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL DEATH; CELL LINE; CELL NUCLEUS; CHICKENS; DNA; HUMANS; HYDROGEN-ION CONCENTRATION; LUCIFERASES; MUTATION; NF-KAPPA B; ONCOGENE PROTEINS V-REL; PEPTIDES; PHOSPHORYLATION; PLASMIDS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERINE; SPLEEN; TRANS-ACTIVATION (GENETICS); TRANSFECTION;

ANIMALIA; GALLUS GALLUS;

EID: 0037371312     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.5.1520-1533.2003     Document Type: Article

References (83)

1. Abbadie, C., N. Kabrun, F. Bouali, J. Smardova, D. Stéhelin, B. Vandenbunder, and P. J. Enrietto. 1993. High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell 75:899-912.
2. Arlt, A., O. Grobe, A. Sieke, M. L. Kruse, U. R. Folsch, W. E. Schmidt, and H. Schafer. 2001. Expression of the NF-κB target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in HeLa cells. Oncogene 20:69-76.
3. Barkett, M., and T. D. Gilmore. 1999. Control of apoptosis by Rel/NF-κB transcription factors. Oncogene 18:6910-6924.
4. Beg, A. A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782-784.
5. Boyle, W., P. van der Greer, and T. Hunter. 1991. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201:110-149.
6. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
7. Catz, S. D., and J. L. Johnson. 2001. Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer. Oncogene 20:7342-7351.
8. Chen, C., F. Agnés, and C. Gélinas. 1999. Mapping of a serine-rich domain essential for the transcriptional, antiapoptotic, and transforming activities of the v-Rel oncoprotein. Mol. Cell. Biol. 19:307-316.
9. Chen, C., F. Agnés, and C. Gélinas. 2001. Mapping of a serine-rich domain essential for the transcriptional, antiapoptotic, and transforming activities of the v-Rel oncoprotein. Mol. Cell. Biol. 21:7115. (Author's correction.)
10. Chen, C., L. C. Edelstein, and C. Gélinas. 2000. The Rel/NF-κB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol. Cell. Biol. 20:2687-2695.
11. Chen, F., L. M. Demers, V. Vallyathan, Y. Lu, V. Castranova, and X. Shi. 1999. Involvement of 5′-flanking κB-like sites within bcl-x gene in silica-induced Bcl-x expression. J. Biol. Chem. 274:35591-35595.
12. Chen, F. E., D. B. Huang, Y. Q. Chen, and G. Ghosh. 1998. Crystal structure of p50/p65 heterodimer of transcription factor NF-κB bound to DNA. Nature 391:410-413.
13. Chen, L., W. Fischle, E. Verdin, and W. C. Greene. 2001. Duration of nuclear NF-κB action regulated by reversible acetylation. Science 293:1653-1657.
14. Chen, Y. Q., S. Ghosh, and G. Ghosh. 1998. A novel DNA recognition mode by the NF-κB p65 homodimer. Nat. Struct. Biol, 5:67-73.
15. Cheng, Q., H. H. Lee, Y. Li, T. P. Parks, and G. Cheng. 2000. Upregulation of Bcl-x and Bfl-1 as a potential mechanism of chemoresistance, which can be overcome by NF-κB inhibition. Oncogene 19:4936-4940.
16. Chu, Z. L., T. A. McKinsey, L. Liu, J. J. Gentry, M. H. Malim, and D. W. Ballard. 1997. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control. Proc. Natl. Acad. Sci. USA 94:10057-10062.
17. Cramer, P., C. J. Larson, G. L. Verdine, and C. W. Muller. 1997. Structure of the human NF-κB p52 homodimer-DNA complex at 2.1 Å resolution. EMBO J. 16:7078-7090.
18. Dougherty, J. P., and H. M. Temin. 1986. High mutation rate of a spleen necrosis virus-based retrovirus vector. Mol. Cell. Biol. 6:4387-4395.
19. Dougherty, J. P., R. Wisniewski, S. Yang, B. W. Rhode, and H. M. Temin. 1989. New retrovirus helper cells with almost no nucleotide sequence homology to retrovirus vectors. J. Virol. 63:3209-3212.
20. Finco, T. S., J. K. Westwick, J. L. Norris, A. A. Beg, C. J. Der, and A. S. Baldwin. 1997. Oncogenic Ha-Ras-induced signaling activates NF-κB transcriptional activity, which is required for cellular transformation. J. Biol. Chem. 272:24113-24116.
21. Fujii, M., T. Minamino, M. Nomura, K.-I. Miyamoto, J. Tanaka, and M. Seiki. 1996. Selective activation of the proto-oncogene c-jun promoter by the transforming protein v-Rel. Oncogene 12:2193-2202.
22. Furia, B., L. Deng, K. Wu, S. Baylor, K. Kehn, H. Li, R. Donnelly, T. Coleman, and F. Kashanchi. 2002. Enhancement of nuclear factor-κ B acetylation by coactivator p300 and HIV-1 Tat proteins. J. Biol. Chem. 277:4973-4980.
23. Ghosh, G., G. Van Duyne, S. Ghosh, and P. B. Sigler. 1995. Structure of NF-κB p50 homodimer bound to a κB site. Nature 373:303-310.
24. Gilmore, T. D., C. Cormier, J. Jean-Jacques, and M. E. Gapuzan. 2001. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel. Oncogene 20:7098-7103.
25. Grumont, R. J., I. J. Rourke, and S. Gerondakis. 1999. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev. 13:400-411.
26. Hettmann, T., J. DiDonato, M. Karin, and J. M. Leiden. 1999. An essential role for nuclear factor κB in promoting double positive thymocyte apoptosis. J. Exp Med 189:145-158.
27. 1-to-S-phase transition. Mol. Cell. Biol. 19:2690-2698.
28. Hrdlickova, R., J. Nehyba, and H. R. Bose, Jr. 2001. Interferon regulatory factor 4 contributes to transformation of v-Rel-expressing fibroblasts. Mol. Cell. Biol. 21:6369-6386.
29. Huang, D. B., Y. Q. Chen, M. Ruetsche, C. B. Phelps, and G. Ghosh. 2001. X-ray crystal structure of proto-oncogene product c-Rel bound to the CD28 response element of IL-2. Structure 9:669-678.
30. Kralova, J., A. S. Liss, W. Bargmann, and H. R. Bose, Jr. 1998. AP-1 factors play an important role in transformation induced by the v-rel oncogene. Mol. Cell. Biol. 18:2997-3009.
31. Krikos, A., C. D. Laherty, and V. M. Dixit. 1992. Transcriptional activation of the tumor necrosis factor a-inducible zinc finger protein, A20, is mediated by κB elements. J. Biol. Chem. 267:17971-17976.
32. Kumar, S., A. B. Rabson, and C. Gélinas. 1992. The RxxRxRxxC motif conserved in all Rel/κB proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoprotein. Mol. Cell. Biol. 12:3094-3106.
33. Kurland, J. F., R. Kodym, M. D. Story, K. B. Spurgers, T. J. McDonnell, and R. E. Meyn. 2001. NF-κB1 (p50) homodimers contribute to transcription of the bcl-2 oncogene. J. Biol. Chem. 276:45380-45386.
34. Laherty, C. D., N. D. Perkins, and V. M. Dixit. 1993. Human T cell leukemia virus type I Tax and phorbol 12-myristate 13-acetate induce expression of the A20 zinc finger protein by distinct mechanisms involving nuclear factor κB. J. Biol. Chem. 268:5032-5039.
35. Lee, H. H., H. Dadgostar, Q. Cheng, J. Shu, and G. Cheng. 1999. NF-κB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. LISA 96:9136-9141.
36. Liu, J., M. Sodeoka, W. Lane, and G. L. Verdine. 1994. Evidence for a non-α-helical DNA-binding motif in the Rel homology region. Proc. Natl. Acad. Sci. USA 91:908-912.
37. Ludwig, L., H. Kessler, M. Wagner, C. Hoang-Vu, H. Dralle, G. Adler, B. O. Bohm, and R. M. Schmid. 2001. Nuclear factor-κB is constitutively active in C-cell carcinoma and required for RET-induced transformation. Cancer Res. 61:4526-4535.
38. Luo, K. X., T. R. Hurley, and B. M. Sefton. 1991. Cyanogen bromide cleavage and proteolytic peptide mapping of proteins immobilized to membranes. Methods Enzymol. 201:149-152.
39. Madrid, L. V., M. W. Mayo, J. Y. Reuther, and A. S. Baldwin, Jr. 2001. Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem. 276:18934-18940.
40. Martin, A. G., and M. Fresno. 2000. TNFα activation of NF-κB requires the phosphorylation of Ser 471 in the transactivation domain of c-Rel. J. Biol. Chem. 275:24383-24391.
41. Mayo, M. W., C. Y. Wang, P. C. Cogswell, K. S. Rogers-Graham, S. W. Lowe, C. J. Der, and A. S. Baldwin. 1997. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 278:1812-1815.
42. c-rel. Mol. Cell. Biol. 11:5867-5877.
43. Muller, C. W., F. A. Rey, M. Sodeoka, G. L. Verdine, and S. C. Harrison. 1995. Structure of the NF-κB p50 homodimer bound to DNA. Nature 373:311-317.
44. Nakayama, K., H. Shimizu, K. Mitomo, T. Watanabe, S.-I. Okamoto, and K.-I. Yamamoto. 1992. A lymphoid cell-specific nuclear factor containing c-Rel-like proteins preferentially interacts with interleukin-6 κB-related motifs whose activities are repressed in lymphoid cells. Mol. Cell. Biol. 12:1736-1746.
45. Neiman, P. E., S. J. Thomas, and G. Loring. 1991. Induction of apoptosis during normal and neoplastic B-cell development in the bursa of Fabricius. Proc. Natl. Acad. Sci. USA 88:5857-5861.
46. Pahl, H. L. 1999. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18:6853-6866.
47. Park, I. C., S. H. Lee, D. Y. Whang, W. S. Hong, S. S. Choi, H. S. Shin, T. B. Choe, and S. I. Hong. 1997. Expression of a novel Bcl-2 related gene, Bfl-1, in various human cancers and cancer cell lines. Anticancer Res. 17:4619-4622.
48. Rao, P. H., J. Houldsworth, K. Dyomina, N. Z. Parsa, J. C. Cigudosa, D. C. Louie, L. Popplewell, K. Offit, S. C. Jhanwar, and R. S. Chaganti. 1998. Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood 92:234-240.
49. Rayet, B., and C. Gélinas. 1999. Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18:6938-6947.
50. Reuther, J. Y., G. W. Reuther, G. Cortez, A. M. Pendergast, and A. S. Baldwin, Jr. 1998. A requirement for NF-κB activation in Bcr-Abl-mediated transformation. Genes Dev. 12:968-981.
51. Romero, P., and E. H. Humphries. 1995. A mutant v-rel with increased ability to transform B lymphocytes. J. Virol. 69:301-307.
52. Rosenwald, A., G. Wright, C. W. C., J. M. Conners, E. Campo, R. I. Fisher, R. D. Gascoyne, H. K. Muller-Hermelink, E. B. Smeland, J. M. H. Giltnane, E. M., H. Zhao, L. Averett, L. Yang, W. H. Wilson, E. S. Jaffe, R. Simon, R. D. Klausner, J. Powell, P. L. Duffey, D. L. Longo, T. C. Greiner, D. D. Weisenburger, W. G. Sanger, B. J. Dave, J. C. Lynch, J. Vose, J. O. Armitage, E. Montserrat, A. Lopez-Guillermo, T. M. Grogan, T. P. Miller, M. LeBlanc, G. Ott, S. Kvaloy, J. Delabie, H. Holte, P. Krajci, T. Stokke, and L. M. Staudt. 2002. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med. 346:1937-1947.
53. Sachdev, S., J. A. Diehl, T. A. McKinsey, A. Hans, and M. Hannink. 1997. A threshold nuclear level of the v-Rel oncoprotein is required for transformation of avian lymphocytes. Oncogene 14:2585-2594.
54. Sakurai, H., H. Chiba, H. Miyoshi, T. Sugita, and V.M. Toriumi. 1999. IκB kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 274:30353-30356.
55. Sarma, V., Z. Lin, L. Clark, B. M. Rust, M. Tewari, R. J. Noelle, and V. M. Dixit. 1995. Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J. Biol. Chem. 270:12343-12346.
56. Schafer, H., A. Arlt, A. Trauzold, A. Hunermann-Jansen, and W. E. Schmidt. 1999. The putative apoptosis inhibitor IEX-1L is a mutant nonspliced variant of p22(PRG1/IEX-1) and is not expressed in vivo. Biochem. Biophys. Res. Commun. 262:139-145.
57. Schilling, D., M. R. Pittelkow, and R. Kumar. 2001. IEX-1, an immediate early gene, increases the rate of apoptosis in keratinocytes. Oncogene 20:7992-7997.
58. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res. 17:6419.
59. Sohur, U. S., C. L. Chen, D. J. Hicks, F. E. Yull, and L. D. Kerr. 2000. Nuclear factor-κB/Rel is apoptogenic in cytokine withdrawal-induced programmed cell death. Cancer Res. 60:1202-1205.
60. Sonenshein, G. E. 1997. Rel/NF-κB transcription factors and the control of apoptosis. Semin. Cancer Biol. 8:113-119.
61. Song, H. Y., M. Rothe, and D. V. Goeddel. 1996. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-κB activation. Proc. Natl. Acad. Sci. USA 93:6721-6725.
62. Stehlik, C., R. de Martin, I. Kumabashiri, J. A. Schmid, B. R. Binder, and J. Lipp. 1998. Nuclear factor (NF)-κB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J. Exp. Med. 188:211-216.
63. Udalova, I. A., R. Mott, D. Field, and D. Kwiatkowski. 2002. Quantitative prediction of NF-κB DNA-protein interactions. Proc. Natl. Acad. Sci. USA 99:8167-8172.
64. Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787-789.
65. Van Der Greer, P., K. Luo, B. M. Sefton, and T. Hunter. 1999. Phosphopeptide mapping and phosphoamino acid analysis on cellulose thin-layer plates, p. 97-126. In D. G. Hardie (ed.), Protein phosphorylation, 2nd ed. Oxford University Press, New York, N.Y.
66. Walker, A. K., and P. J. Enrietto. 1996. Analysis of the role of v-rel in transcriptional regulation of high mobility group protein 14. Oncogene 12:2515-2525.
67. Wang, C. Y., M. W. Mayo, and A. S. Baldwin, Jr. 1996. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274:784-787.
68. Wang, C. Y., M. W. Mayo, R. G. Korneluk, D. V. Goeddel, and A. S. Baldwin, Jr. 1998. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281:1680-1683.
69. Wang, D., and A. S. Baldwin, Jr. 1998. Activation of NF-κB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529. J. Biol. Chem. 273:29411-29416.
70. Wang, D., S. D. Westerheide, J. L. Hanson, and A. S. Baldwin, Jr. 2000. Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II. J. Biol. Chem. 275:32592-32597.
71. Watanabe, S., and H. M. Temin. 1983. Construction of a helper cell line for avian reticuloendotheliosis virus cloning vectors. Mol. Cell. Biol. 3:2241-2249.
72. 1 transition. Mol. Cell. Biol. 21:8428-8436.
73. White, D. W., and T. D. Gilmore. 1996. Bcl-2 and CrmA have different effects on transformation, apoptosis and the stability of IκB-α in chicken spleen cells transformed by temperature-sensitive v-Rel oncoproteins. Oncogene 13:891-899.
74. White, D. W., A. Roy, and T. D. Gilmore. 1995. The v-Rel oncoprotein blocks apoptosis and proteolysis of IκB-a in transformed chicken spleen cells. Oncogene 10:857-868.
75. Wu, M., H. Lee, R. E. Bellas, S. L. Schauer, M. Arsura, D. Katz, M. J. FitzGerald, T. L. Rothstein, D. H. Sherr, and G. E. Sonenshein. 1996. Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J. 15:4682-4690.
76. Wu, M. X., Z. Ao, K. V. S. Prasad, R. Wu, and S. F. Schlossman. 1998. IEX-1L, an apoptosis inhibitor involved in NF-κB-mediated cell survival. Science 281:998-1001.
77. Xu, X., C. Prorock, H. Ishikawa, E. Maldonado, Y. Ito, and C. Gélinas. 1993. Functional interaction of the v-Rel and c-Rel oncoproteins with the TATA-binding protein and association with transcription factor IIB. Mol. Cell. Biol. 13:6733-6741.
78. You, M., and H. R. Bose, Jr. 1998. Identification of v-Rel oncogene-induced inhibitor of apoptosis by differential display. Methods 16:373-385.
79. You, M., P. T. Ku, R. Hrdlickova, and H. R. Bose, Jr. 1997. ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein. Mol. Cell. Biol. 17:7328-7341.
80. Zhong, H., R. E. Voll, and S. Ghosh. 1998. Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1:661-671.
81. Zhou, P., L. J. Sun, V. Dotsch, G. Wagner, and G. L. Verdine. 1998. Solution structure of the core NFATC1/DNA complex. Cell 92:687-696.
82. Zong, W. X., L. C. Edelstein, C. Chen, J. Bash, and C. Gélinas. 1999. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis. Genes Dev. 13:382-387.
83. Zong, W. X., M. Farrell, J. Bash, and C. Gélinas. 1997. v-Rel prevents apoptosis in transformed lymphoid cells and blocks TNFα-induced cell death. Oncogene 15:971-980.